Daniel Bergemalm

2.2k total citations
36 papers, 1.0k citations indexed

About

Daniel Bergemalm is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, Daniel Bergemalm has authored 36 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Genetics, 12 papers in Surgery and 12 papers in Epidemiology. Recurrent topics in Daniel Bergemalm's work include Inflammatory Bowel Disease (25 papers), Microscopic Colitis (11 papers) and Amyotrophic Lateral Sclerosis Research (7 papers). Daniel Bergemalm is often cited by papers focused on Inflammatory Bowel Disease (25 papers), Microscopic Colitis (11 papers) and Amyotrophic Lateral Sclerosis Research (7 papers). Daniel Bergemalm collaborates with scholars based in Sweden, Spain and United Kingdom. Daniel Bergemalm's co-authors include Thomas Brännström, Peter M. Andersen, Stefan L. Marklund, P. Andreas Jonsson, Karin S. Graffmo, Karin Forsberg, Ole Gredal, Peter Nilsson, Magnus Hultdin and Johan Jacobsson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and Gastroenterology.

In The Last Decade

Daniel Bergemalm

33 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Bergemalm Sweden	12	702	343	287	219	191	36	1.0k
Lina Benajiba France	11	233 0.3×	185 0.5×	167 0.6×	30 0.1×	23 0.1×	33	549
Aparna Kaul United States	11	120 0.2×	129 0.4×	274 1.0×	24 0.1×	118 0.6×	13	676
Natalia Martín United States	13	59 0.1×	56 0.2×	372 1.3×	160 0.7×	84 0.4×	17	794
Yoshihito Matsumoto Japan	14	107 0.2×	133 0.4×	266 0.9×	24 0.1×	98 0.5×	41	706
Marija Tadin‐Strapps United States	14	76 0.1×	29 0.1×	255 0.9×	65 0.3×	81 0.4×	19	596
Claire J. Cairney United Kingdom	17	78 0.1×	59 0.2×	453 1.6×	43 0.2×	33 0.2×	24	784
Yiming Tu China	16	51 0.1×	73 0.2×	491 1.7×	17 0.1×	62 0.3×	32	841
Shilpa Rao India	11	78 0.1×	138 0.4×	348 1.2×	96 0.4×	90 0.5×	86	755
Daniel Beltrán-Valero de Bernabé United States	14	63 0.1×	49 0.1×	743 2.6×	106 0.5×	23 0.1×	16	972

Countries citing papers authored by Daniel Bergemalm

Since Specialization

Citations

This map shows the geographic impact of Daniel Bergemalm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Bergemalm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Bergemalm more than expected).

Fields of papers citing papers by Daniel Bergemalm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Bergemalm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Bergemalm. The network helps show where Daniel Bergemalm may publish in the future.

Co-authorship network of co-authors of Daniel Bergemalm

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Bergemalm. A scholar is included among the top collaborators of Daniel Bergemalm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Bergemalm. Daniel Bergemalm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stenberg, Erik, Åsa H. Everhov, Jonas Söderling, et al.. (2025). Outcomes of inflammatory bowel disease in patients with obesity following bariatric surgery: propensity score-matched cohort study. BJS Open. 9(4).

Bergemalm, Daniel, et al.. (2025). Insulin sensitivity in moderately severe to acute severe ulcerative colitis. Scandinavian Journal of Gastroenterology. 60(3). 243–247.

Peterson, Christer, Charlotte Hedin, Daniel Bergemalm, et al.. (2024). Faecal biomarkers for diagnosis and prediction of disease course in treatment‐naïve patients with IBD. Alimentary Pharmacology & Therapeutics. 60(6). 765–777. 7 indexed citations

Sudhakar, Padhmanand, Daniel Bergemalm, Marie Carlson, et al.. (2024). Characterization of Inflammatory Bowel Disease Heterogeneity Using Serum Proteomics: A Multicenter Study. Journal of Crohn s and Colitis. 19(5). 1 indexed citations

Eriksson, Carl, Per Karlén, Olof Grip, et al.. (2023). Long-term outcomes of vedolizumab in inflammatory bowel disease: the Swedish prospective multicentre SVEAH extension study. Therapeutic Advances in Gastroenterology. 16. 1108357929–1108357929. 4 indexed citations

Bergemalm, Daniel, et al.. (2023). Comparative study of a point-of-care test and an enzyme-linked immunosorbent assay (ELISA) for infliximab levels. Scandinavian Journal of Gastroenterology. 59(2). 150–155. 1 indexed citations

Ottosson, Johan, Yang Cao, Ellen Andersson, et al.. (2023). Outcomes of bariatric surgery for patients with prevalent inflammatory bowel disease: A nationwide registry-based cohort study. Surgery. 174(2). 144–151. 4 indexed citations

Eriksson, Carl, Jonas Söderling, Gabriella Bröms, et al.. (2023). Ustekinumab Versus Anti-tumour Necrosis Factor Alpha Agents as Second-Line Biologics in Crohn's Disease. Digestive Diseases and Sciences. 68(7). 3119–3128. 5 indexed citations

Shubhakar, Archana, Bas C. Jansen, Alex Adams, et al.. (2023). Serum N-Glycomic Biomarkers Predict Treatment Escalation in Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 17(6). 919–932. 10 indexed citations

10.

Hedin, Charlotte, Anders Forss, Charlotte Söderman, et al.. (2022). Ustekinumab treatment in ulcerative colitis: Real‐world data from the Swedish inflammatory bowel disease quality register. United European Gastroenterology Journal. 10(7). 631–639. 29 indexed citations

11.

Eriksson, Carl, Lina Vigren, Anders Kärnell, et al.. (2021). Clinical effectiveness of golimumab in ulcerative colitis: a prospective multicentre study based on the Swedish IBD Quality Register, SWIBREG. Scandinavian Journal of Gastroenterology. 56(11). 1304–1311. 6 indexed citations

12.

Eriksson, Carl, Ruzan Udumyan, Per Karlén, et al.. (2021). Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study. Therapeutic Advances in Gastroenterology. 14. 1088206362–1088206362. 19 indexed citations

13.

Verstockt, Bram, Małgorzata Sładek, Nanne K.H. de Boer, et al.. (2021). Orofacial Granulomatosis Associated with Crohn’s Disease: a Multicentre Case Series. Journal of Crohn s and Colitis. 16(3). 430–435. 6 indexed citations

14.

Bergemalm, Daniel, Sofia Ramström, Kjell Hultenby, et al.. (2020). Platelet proteome and function in X−linked thrombocytopenia with thalassemia and <i>in silico</i> comparisons with gray platelet syndrome. Haematologica. 106(11). 2947–2959. 9 indexed citations

15.

Bergemalm, Daniel, Robert L. Kruse, Maria Sapnara, Jonas Halfvarson, & Elisabeth Hultgren Hörnquist. (2017). Elevated fecal peptidase D at onset of colitis in Galphai2-/- mice, a mouse model of IBD. PLoS ONE. 12(3). e0174275–e0174275. 3 indexed citations

16.

Bergemalm, Daniel, et al.. (2017). Subphenotypes of inflammatory bowel disease are characterized by specific serum protein profiles. PLoS ONE. 12(10). e0186142–e0186142. 27 indexed citations

17.

Kalla, Rahul, Alex Adams, Simen Vatn, et al.. (2017). Proximity Extension Assay based Proteins Show Immune Cell Specificity and can Diagnose and Predict Outcomes in Inflammatory Bowel Diseases: IBD Character Study. Gastroenterology. 152(5). S606–S607. 1 indexed citations

18.

Kalla, Rahul, Nicholas A. Kennedy, Fredrik Hjelm, et al.. (2015). P140. Proximity Extension Assay technology identifies novel serum biomarkers for predicting Inflammatory Bowel Disease: IBD Character Consortium. Journal of Crohn s and Colitis. 9(suppl 1). S146–S147. 1 indexed citations

19.

Bergemalm, Daniel, Karin Forsberg, Vaibhav Srivastava, et al.. (2010). Superoxide dismutase‐1 and other proteins in inclusions from transgenic amyotrophic lateral sclerosis model mice. Journal of Neurochemistry. 114(2). 408–418. 37 indexed citations

20.

Bergemalm, Daniel, P. Andreas Jonsson, Karin S. Graffmo, et al.. (2006). Overloading of Stable and Exclusion of Unstable Human Superoxide Dismutase-1 Variants in Mitochondria of Murine Amyotrophic Lateral Sclerosis Models. Journal of Neuroscience. 26(16). 4147–4154. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact